cefadroxil anhydrous has been researched along with phenylalanylalanine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Biegel, A; Brandsch, M; Gebauer, S; Hartrodt, B; Neubert, K; Thondorf, I | 1 |
| Aldini, G; De Luca, L; Marconi, C; Pedretti, A; Regazzoni, L; Vistoli, G | 1 |
| Amasheh, S; Bachfischer, U; Daniel, H; Döring, F; Dorn, D; Herget, M | 1 |
3 other study(ies) available for cefadroxil anhydrous and phenylalanylalanine
| Article | Year |
|---|---|
Three-dimensional quantitative structure-activity relationship analyses of beta-lactam antibiotics and tripeptides as substrates of the mammalian H+/peptide cotransporter PEPT1.
Topics: Animals; beta-Lactams; Cell Line, Tumor; Dipeptides; Drug Design; Humans; Mammals; Models, Molecular; Oligopeptides; Peptide Transporter 1; Quantitative Structure-Activity Relationship; Substrate Specificity; Symporters | 2005 |
Fragmental modeling of hPepT2 and analysis of its binding features by docking studies and pharmacophore mapping.
Topics: Binding Sites; Computer Simulation; Drug Design; Humans; Ligands; Models, Molecular; Peptides; Protein Binding; Structural Homology, Protein; Symporters | 2011 |
Functional analysis of a chimeric mammalian peptide transporter derived from the intestinal and renal isoforms.
Topics: Animals; Carrier Proteins; Cefadroxil; Dipeptides; Escherichia coli; Evoked Potentials; Humans; Hydrogen-Ion Concentration; Oocytes; Peptide Transporter 1; Rabbits; Recombinant Fusion Proteins; Substrate Specificity; Symporters; Xenopus | 1996 |